Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: A survey of adult and pediatric providers

American Journal of Infection Control

Volumn 38, Issue 4, 2010, Pages 324-328

  Mascitti, Kara B ^a   Gerber, Jeffrey S ^b   Zaoutis, Theoklis E ^a,b   Barton, Todd D ^a   Lautenbach, Ebbing ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Methicillin resistant Staphylococcus aureus; questionnaire; skin infections; soft tissue infections

Indexed keywords

ANTIINFECTIVE AGENT; BLEACHING AGENT; CEFALEXIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; LINEZOLID; MINOCYCLINE; PSEUDOMONIC ACID; RIFAMPICIN;

ARTICLE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; INTERNET; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RECURRENT INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; UNITED STATES;

ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RECURRENCE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 77951957974     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2009.11.007     Document Type: Article

References (10)

1. Fridkin S.K., Hageman J.C., Morrison M., Sanza L.T., Como-Sabetti K., Jernigan J.A., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352 (2005) 1436-1444
2. Gorwitz R.J. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 27 (2008) 1-7
3. Miller L.G., Quan C., Shay A., Mostafaie K., Bharadwa K., Tan N., et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis 44 (2007) 483-492
4. Stevens D.L., Bisno A.L., Chambers H.F., Everett E.D., Dellinger P., Goldstein E.J., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41 (2005) 1373-1406
5. Gorwitz RJ, Jernigan DB, Powers JH. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available from: http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html. Accessed July 1, 2009.
6. Creech C.B., Beekmann S.E., Chen Y., and Polgreen P.M. Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 27 (2008) 270-272
7. Hammond S.P., and Baden L.R. Clinical decisions: management of skin and soft-tissue infection-polling results. N Engl J Med 359 (2008) e20
8. Elliott D.J., Zaoutis T.E., Troxel A.B., Loh A., and Keren R. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Pediatrics 123 (2009) e959-e966
9. Diep B.A., Chambers H.F., Graber C.J., Szumowski J.D., Miller L.G., Han L.L., et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 148 (2008) 249-257
10. Miller L.G., and Diep B.A. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46 (2008) 752-760